Shree Ganesh Remedies has informed that the Board of Directors of the Company at its meeting held today, October 23, 2022 has considered and approved the Unaudited Financial Results as per Indian Accounting Standards (IND AS) for the quarter and half year ended September 30, 2022, along with the review report of Auditors thereon pursuant to regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (enclosed herewith). The Meeting of the Board of Directors of the Company commenced at 10.00 am and concluded at 11.20 am.
The above information is a part of company’s filings submitted to BSE.
